loader2
Partner With Us NRI

Advanced Enzyme Technologies Ltd share Price Today

Company details

372.50
385.00
284.15
425.15
6M Return 2.23%
1Y Return 32.69%
Mkt Cap.(Cr) 4,210.17
Volume 272,077
Div Yield 1.36%
OI
-
OI Chg %
-
Volume 272,077
NSE

Open Free Trading Account Online with ICICIDIRECT

Incur '0' Brokerage upto ₹500

Biotechnology company Advanced Enzyme Technologies announced consolidated Q4FY24 & FY24 results:

Q4FY24 Financial Highlights:

  • Revenue from Operations: Revenue from operations on consolidated basis increased to Rs 1,578 million in the Q4FY24 from Rs 1,387 million in the Q4FY23, a growth of 14%.
  • Profit: Consolidated EBITDA during Q4FY24 stands at Rs 554 million as compared to Rs 441 million during Q4FY23, an increase of 26%.
  • Profit before tax stands at Rs 397 million during Q4FY24 as against Rs 421 million in Q4FY23, decrease of 6%.
  • Profit after tax de-grew by 7% and stands at Rs 299 million during Q4FY24 as compared to Rs 321 million during the Q4FY23.
  • Margin: EBITDA margin stands at 35%, PBT margin stands at 25% and PAT margin stood at 19% during the quarter.
  • Financial Costs: Financial costs stood at Rs 8 million during Q4FY24 as against Rs 6 million in Q4FY23.
  • Depreciation and Amortization: Depreciation and Amortization charge for the Q4FY24 stood at Rs 93 million as compared to Rs 84 million, the same quarter previous year.
  • Earnings Per Share: Earnings Per Share during Q4FY24 stands at Rs 2.53 as compared to Rs 2.87 in Q4FY23.

FY24 Financial Highlights:

  • Revenue from Operations: Revenue from operations on consolidated basis increased to Rs 6,239 million in the FY24 from Rs 5,406 million in the FY23, reported an increase of 15%.
  • Profit: Consolidated EBITDA during FY24 stands at Rs 2,045 million as compared to Rs 1,546 million during FY23, growth of 31%.
  • Profit before tax stands at Rs 1,879 million during FY24 as against Rs 1,404 million in FY23, an increase of 34%
  • Profit after tax stands at Rs 1,370 million during FY24 as compared to Rs 1,039 million during the FY23, an increase of 32%.
  • Margin: EBITDA margin stands at 33%, PBT margin stands at 30% and PAT margin stands at 22% during the FY24.
  • Financial Costs: Financial costs stood at Rs 29 million during FY24 as against Rs 24 million in FY23.
  • Depreciation and Amortization: Depreciation and Amortization charge for the FY24 is Rs 353 million as compared to Rs 350 million in FY23.
  • Earnings Per Share: Earnings Per Share during FY24 stands at Rs 11.92 as compared to Rs 9.45 in FY23.

Result PDF

View Other Company Results

Advanced Enzyme Technologies Ltd shares SWOT Analysis

Strengths (4)

  • Company with Low Debt
  • Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
  • Book Value per share Improving for last 2 years

Weakness (0)

Data not found

Opportunity (1)

  • Big Deal (Insider and SAST) buys last month greater than 1% of total shares

Threats (2)

  • Promoter decreasing their shareholding
  • Companies with growing costs YoY for long term projects
Discover More

Resistance and support

R1 383.5
R2 390.5
R3 396.0
Pivot

378.00

S1 371.0
S2 365.5
S3 358.5
EMA SMA
380.6
377.8
373.7
360.6
382.2
376.6
375.2
362.9
Delivery and volume
Discover More
CLIENT NAME DEAL TYPE ACTION DATE AVG. PRICE QUANTITY EXCHANGE
MOTILAL OSWAL FINANCIAL SERVICES LIMITED Bulk Purchase 2024-06-19 385 11053245 NSE
ORBIMED ASIA III MAURITIUS LIMITED Bulk Sell 2024-06-19 385 11053245 NSE
MOTILAL OSWAL FINANCIAL SERVICES LIMITED Block Purchase 2024-06-19 385 11053245 NSE
Discover More

OUR RESEARCH VIEW

Investment recommendation
Good recovery in FY24; momentum likely to persist…
Call Date
17 May 2024
Entry Price 375.00
Target Price 470.00
Duration
12-18 Month
BUY View Report
DISCOVER MORE

FINANCIALS

Sales
Operating Profit
Profit after Tax
DISCOVER MORE
Equity
Reserves and Surplus
Debt
DISCOVER MORE
Sales
Operating Profit
Profit after Tax
DISCOVER MORE
PE
Debt/Equity
P BV
DISCOVER MORE

Advanced Enzyme Technologies Ltd Stocks COMPARISON

Financials( ₹ in Cr) Advanced Enzyme Technologies Ltd Sun Pharmaceuticals Industries Ltd Cipla Ltd Divis Laboratories Ltd Zydus Lifesciences Ltd
Price 376.50 1,579.30 1,510.40 4,570.80 1,184.80
% Change -2.07 -1.20 -0.19 -1.43 0.39
Mcap ₹ Cr 4,210.17 378,926.98 121,944.71 121,340.57 119,218.60
Revenue TTM ₹ Cr 623.87 48,496.85 15,790.60 7,665.00 19,547.40
Net Profit TTM ₹ Cr 136.95 9,648.44 2,513.47 1,576.00 3,854.40
PE TTM 29.15 37.93 28.66 75.74 30.89
1 Year Return 32.69 51.13 48.56 25.57 103.71
ROCE 14.53 17.20 14.76 16.27 23.94
ROE 10.70 16.13 10.66 12.04 20.64
DISCOVER MORE
INSIDER & INSTITUTIONAL ACTIVITY

Equity Capital: 1,324.13 Cr FV: 2.00

Period MF Net Purchase / (sold) FII Net
LAST 1M 21,424.68 50,451.86
LAST 3M 101,404.97 51,097.20
LAST 6M 186,293.66 40,305.54
LAST 12M 309,547.75 87,515.42

Advanced Enzyme Technologies Ltd Information

Stock PE (TTM)
29.15
Promoter Holding
43.02%
Book Value
118.4117
ROCE
14.53%
ROE
10.7%
Description

  • Advanced Enzyme Technologies Limited is a manufacturing enzymes sector company having a market capitalization of is 5,100.96 Crores as of 15-May-2021. The company was incorporated in 1945. The company has reported its consolidated quarterly revenue of Rs. 139.09 Cr. at the end of December 2020. The company is found listed on the Bombay Stock Exchange (BSE) with the code 540025 and also listed on National Stock Exchange (NSE) with the symbol ADVENZYMES. Advanced Enzymes is the largest Indian enzyme company engaged in the research and development dedicated to marketing eco-safe solutions to a wide variety of industries like Pharmaceuticals, Baking, Agriculture, Waste Management, Textile, Leather, Distilling, Grain Processing, Juice Processing, etc, developed from over 65 indigenous enzymes & probiotics. As of March 31, 2020, the Company has 6 (six) direct subsidiaries and 5 (five) step-down subsidiaries. Out of which 3 (three) are Indian subsidiaries and 8 (eight) are foreign subsidiaries make a strong presence across 45 countries worldwide. With exports across 6 continents, they provide customized and effective enzyme solutions coupled with the best in technical advice and superior service. 20 patents. The company has granted more than 20 patents, currently having more than 550 employees, more than 25 years of fragmentation experience. The current fragmentation capacity of AETL is 470 m³. To strength, its product, Company spending on R & D as a percentage of turnover is increasing from past 4 years( As per March 2020, R & D cost to total turnover is 4.95%) Advanced Enzyme Technologies Limited (AETL) is having is earning 43% revenue from India and 57% revenue internationally. ATL is having high TTM EPS growth with Low debt. For F.Y 19-20. Annual net profits and Book value per share also increasing for the past 2 years. ATL is a company having zero promoter pledges and Strong cash-generating ability from its core business. As on 31-March 20, AETL is a company having zero promoter pledge and Strong cash-generating ability from core business.

Read More
Registered Address

Sun Magnetica 5th Floor, Nr LIC Serivce Road Louiswadi, Thane, Maharashtra, 400604

Tel : 91-22-41703200
Email : sanjay:advancedenzymes.com; info:advancedenzymes.c
Website : http://www.advancedenzymes.com
Registrar

Link Intime India Pvt Ltd

AGM Date (Month) : Aug
Face Value Equity Shares : 2
Market Lot Equity Shares : 1
BSE Code : 540025
NSE Code : ADVENZYMES
Book Closure Date (Month) :
BSE Group : B
ISIN : INE837H01020

FAQ’s on Advanced Enzyme Technologies Ltd Shares

You can buy Advanced Enzyme Technologies Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Advanced Enzyme Technologies Ltd Share.

Company share prices and volatile and keep changing according to the market conditions. As of Jul 16, 2024 03:56 PM the closing price of Advanced Enzyme Technologies Ltd was Rs.376.50.

The latest PE ratio of Advanced Enzyme Technologies Ltd as of Jul 16, 2024 03:56 PM is 29.15

The latest PB ratio of Advanced Enzyme Technologies Ltd as of Jul 16, 2024 03:56 PM is 0.31

The 52-week high of Advanced Enzyme Technologies Ltd share price is Rs. 425.15 while the 52-week low is Rs. 284.15

According to analyst recommendations, Advanced Enzyme Technologies Ltd Share has a "Buy" rating for the long term.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of Jul 16, 2024 03:56 PM, the market cap of Advanced Enzyme Technologies Ltd stood at Rs. 4,210.17 Cr.

Download App

Download Our App

Play Store App Store
market app